Clinical Trials on Klebsiella Pneumonia

Total 9649 results

LimmaTech Biologics AG
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

Klebsiella Pneumoniae Infection

Germany
Sir Run Run Shaw Hospital

Unknown

Epidemiology of Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection

China
Sir Run Run Shaw Hospital

Unknown

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection

China
National Taiwan University Hospital

Unknown

Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.

Klebsiella Pneumoniae Sepsis

Taiwan
Maimónides Biomedical Research Institute of Córdoba

Completed

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

Patients Colonized by Klebsiella Pneumoniae.
Hadassah Medical Organization
Tel Aviv University

Unknown

Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia

Anti-Biotic Resistance | Klebsiella Pneumoniae

Israel
Huashan Hospital
Sumitomo Pharmaceuticals (Suzhou) Co. Ltd

Unknown

WGS-guided Tracking and Infection Control Measures of CRKP

Klebsiella Pneumoniae Infection

China
Rambam Health Care Campus

Completed

A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).

Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia

Israel
National Taiwan University Hospital

Completed

Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features

Necrotizing Fasciitis

Taiwan
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections

Carbapenem | Klebsiella Pneumonia
Soroka University Medical Center

Unknown

SDD for Eradicating CRKP Carriage

Carriers of Carbapenem-resistant Klebsiella Pneumonia

Israel
Phramongkutklao College of Medicine and Hospital
Silpakorn University

Recruiting

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

Carbapenem Resistant Klebsiella Pneumoniae

Thailand
American University of Beirut Medical Center
Merck Sharp & Dohme LLC

Completed

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Escherichia Coli Infections | Klebsiella Pneumonia

Lebanon
Koç University

Completed

Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia (THREAT)

Bacteremia | Klebsiella Pneumonia

Turkey
Al-Azhar University

Unknown

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae

Egypt
Universidad del Norte

Unknown

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

Urinary Tract Infections | Enterobacteriaceae Infections | Clinical Trial | Carbapenem | Klebsiella Pneumoniae Infection | Infection Due to ESBL Bacteria | Escherichia Coli Infection | Drug Resistance, Bacterial

Colombia
Maimónides Biomedical Research Institute of Córdoba
Mikrobiomik Healthcare Company S.L.

Recruiting

Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae (KAPEDIS)

Carbapenemase-producing Enterobacteriaceae Infection

Spain
University of Pittsburgh

Completed

Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

Infection | ESBL | Quinolone Resistance | Klebsiella Species

United States
Soroka University Medical Center

Completed

Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae

Carriage of Carbapemen-resistant Klebsialle Pneumoniae

Israel
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure (PoKES2_HYDRES)

Klebsiella Infections

France
West China Hospital

Completed

Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae Infection (HVCRKP)

Infection, Bacterial

China
SCARE (Study group for carbapenem resistance)

Unknown

Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae (COMBAT)

Bloodstream Infection

Turkey
Sohag University

Recruiting

Type VI Secretion System in Klebsiella Pneumoniae (Klebsiella)

Detection of Type VI Secretion System in K.Pneumoniae | Detection of Relation to Ab Resistance, Biofilm

Egypt
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Klebsiella Infections | Escherichia Coli Infections

Korea, Republic of
National University Hospital, Singapore
Singapore General Hospital; Tan Tock Seng Hospital

Completed

Antibiotics for Klebsiella Liver Abscess Study

Liver Abscess, Pyogenic

Singapore
Universidad de la Sabana

Recruiting

Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases. (CAP)

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae Pneumonia | Streptococcus Pneumoniae Infection Invasive

Colombia
University of Oxford
Pfizer

Unknown

Understanding Pneumococcal Carriage and Disease 2017-2020

Streptococcal Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae, Invasive Disease

United Kingdom
Pfizer

Completed

Nasopharyngeal Streptococcus Pneumoniae Carriage

Streptococcus Pneumoniae Infections

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China

Streptococcus Pneumoniae Infections

China
Chongqing Medical University

Terminated

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children (MPP)

Refractory Mycoplasma Pneumoniae Pneumonia
University of Colorado, Denver
Pfizer

Completed

Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection

Guatemala
Christoph Berger

Not yet recruiting

A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study (MYTHIC)

Community Acquired Pneumonia in Children | Mycoplasma Pneumoniae | Mycoplasma Pneumoniae Pneumonia

Switzerland
University of Pittsburgh

Completed

Etiology of Community Acquired Pneumonia (CAP)

Streptococcus Pneumonia | Mycoplasma Pneumonia | Haemophilus Influencae | Chlamydia Pneumonia

United States
University Children's Hospital, Zurich
University Children's Hospital Basel; Ostschweizer Kinderspital

Unknown

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy (myKIDS-STEP)

Community-acquired Pneumonia

Switzerland
Beijing Children's Hospital
Shengjing Hospital; Shanxi Provincial Maternity and Children's Hospital; Baoding... and other collaborators

Completed

Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

Mycoplasma Pneumoniae Pneumonia

China
Fundación Cardiovascular de Colombia

Completed

Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device (Supratube)

Aspiration Pneumonias

Colombia
UMC Utrecht
Netherlands: Ministry of Health, Welfare and Sports; Netherlands Vaccine Institute

Completed

Effect of Two Versus Three Pneumococcal Conjugate Vaccinations (MNOES)

Streptococcus Pneumoniae Infection
GlaxoSmithKline

Completed

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Streptococcus Pneumoniae Vaccines

Sweden
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
Sanofi

Completed

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
GlaxoSmithKline

Completed

Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Mexico
Arto Palmu
GlaxoSmithKline

Completed

Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

Nasopharyngeal Carriage of Streptococcus Pneumoniae

Finland
Boston Medical Center
Merck Sharp & Dohme LLC

Completed

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

Nasopharyngeal Carriage of S. Pneumoniae

United States
GlaxoSmithKline

Withdrawn

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Immunisation Against Streptococcus Pneumoniae
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Mexico
GlaxoSmithKline

Completed

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Vietnam
GlaxoSmithKline

Completed

Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Germany
University of Milan

Unknown

Longitudinal Pattern of Streptococcus Pneumoniae Nasopharyngeal Carriage and Antimicrobial Susceptibility in Healthy Children Aged Less Then 5 Years, in the Area of Milan and Surroundings, Lombardy, Italy.

Streptococcus Pneumoniae Nasopharyngeal Carriage

Italy
Walvax Biotechnology Co., Ltd.

Completed

Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)

Diseases Caused by Streptococcus Pneumoniae Serotypes
GlaxoSmithKline

Completed

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

Streptococcus Pneumoniae Vaccines | Infections, Streptococcal

Poland

Clinical Trials on Klebsiella Pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations